QQ客服 官方微博 反馈留言

浏览/检索结果: 共14条，第1-10条 帮助 限定条件 发表日期：2015    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial 期刊论文 LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 6 作者:  Li, Jin;  Qin, Shukui;  Xu, Ruihua;  Yau, Thomas C. C.;  Ma, Brigette 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/13 Intercalating and Maintenance Use of Gefitinib plus Chemotherapy versus Chemotherapy Alone in Selected Advanced NSCLC: A Phase III Study 会议论文 作者:  Jian, Hong;  Li, Wei;  Ma, Zhiyong;  Huang, Jianjin;  Feng, Jifeng 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/13 lung adenocarcinoma  gefitinib  chemotherapy   Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study) 期刊论文 GASTRIC CANCER, 2015, 卷号: 18, 期号: 1 作者:  Shen, Lin;  Li, Jin;  Xu, Jianming;  Pan, Hongming;  Dai, Guanghai 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/13 Bevacizumab  Gastric adenocarcinoma   Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition). 期刊论文 Annals of translational medicine, 2015, 卷号: 3, 期号: 21 作者:  Guo Jun;  Qin Shukui;  Liang Jun;  Lin Tongyu;  Si Lu 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/13 A post-hoc health-related quality of life (HRQoL) analysis of patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial. 会议论文 作者:  Chang, Jane;  Odom, Dawn;  Radder, Christina;  Kappeler, Christian;  Xu, Rui-hua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 Effects of regorafenib (REG) therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial 会议论文 作者:  Chang, Jane;  Ngai, Christopher;  Odom, Dawn;  Radder, Christina;  Kappeler, Christian 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19 Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study 期刊论文 ONCOTARGETS AND THERAPY, 2015, 卷号: 8 作者:  Qin, Shukui;  Bi, Feng;  Jin, Jie;  Cheng, Ying;  Guo, Jun 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 axitinib  renal cell carcinoma  sorafenib  vascular endothelial growth factor receptor inhibitor   An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer. 会议论文 作者:  He, Jianxing;  Shi, Yuankai;  Chang, Jianhua;  Wang, Mengzhao;  Han, Baohui 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial 会议论文 作者:  Shi, Yuankai;  Wang, Mengzhao;  He, Jianxing;  Chang, Jianhua;  Han, Baohui 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/19 S-1  phase 3 trial  Therapy  NSCLC   Effects of regorafenib therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial. 会议论文 作者:  Qin, Shukui;  Kim, Tae Won;  Yau, Thomas Cheung;  Ma, Brigette;  Pan, Hongming 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19